RxDoctor Payments Data

Derek Dombroski, MD

Orthopaedic Trauma · Olympia, WANPI 1992865869

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (44.4%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. Synthes GmbH accounts for 62.0% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2022 at $7,035 and has fallen 88.5% since, to $810 in 2025.

$14,197in general payments, 2019–2025

Across 55 payments — averaging $258.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Synthes GmbH$9K
  • Smith+Nephew$3K
  • Acumed LLC$1K
  • Stryker$342
  • Johnson & Johnson$332
  • Elevate Surgical Co$307
  • plus $704 from 7 others

What the payments were for

  • Speaking & faculty fees$4,75033%
  • Travel & lodging$6,29844%
  • Food & beverage$3,15022%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Synthes GmbH10$8,798
Smith+Nephew18$2,664
Acumed LLC2$1,050
Stryker6$342
Johnson & Johnson5$332
Elevate Surgical Co4$307
Zimmer Biomet3$208
Cepheid2$206
Amgen1$117
Davol Inc.1$86
Illuminoss Medical, Inc.1$49
Bioventus LLC1$21
Polynovo North America LLC1$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$14,197 in reported general payments places this provider in the 60th percentile of 33 orthopaedic trauma providers in Washington.

See all orthopaedic trauma providers in Washington

Medicare billing

Part B allowed, 2024
$121,890
Medicare patients
160
Services billed
540

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin16$181

Paid to pharmacies, not to this prescriber.

Other orthopaedic trauma in Olympia

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →